Binex Co

Binex Co Current Liabilities

The Current Liabilities of Binex Co (053030.KQ) as of Oct 27, 2026 is 4.39 B KRW. In the previous year, Current Liabilities was 72.51 B KRW — a change of -93.94% (lower).

Current Liabilities

4.39 BKRW

YoY

-93.94%

Last updated:

Current Liabilities of Binex Co is 2025 4.39 B KRW. Current Liabilities of Binex Co was 2024 72.51 B KRW. It decreases by -93.94% lower compared to the previous year.

The Binex Co Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2018
37.30 B KRW
Jan 1, 2019
60.96 B KRW
Jan 1, 2020
28.99 B KRW
Jan 1, 2021
32.71 B KRW
Jan 1, 2022
65.45 B KRW
Jan 1, 2023
55.31 B KRW
Jan 1, 2024
72.51 B KRW
Jan 1, 2025
4.39 B KRW
The Binex Co Current Liabilities history
YEARCurrent LiabilitiesYoY
4.39 BKRW-93.94%
72.51 BKRW+31.10%
55.31 BKRW-15.50%
65.45 BKRW+100.11%
32.71 BKRW+12.82%
28.99 BKRW-52.44%
60.96 BKRW+63.41%
37.30 BKRW+16.14%
32.12 BKRW-38.10%
51.89 BKRW+458.30%
9.29 BKRW-34.05%
14.09 BKRW-32.23%
20.80 BKRW-33.87%
31.45 BKRW+101.31%
15.62 BKRW+59.74%
9.78 BKRW-47.44%
18.61 BKRW+164.61%
7.03 BKRW+41.66%
4.96 BKRW-11.73%
5.62 BKRW+2.22%
5.50 BKRW+1.62%
5.41 BKRW-10.65%
6.06 BKRW-1.99%
6.18 BKRW+8.36%
5.70 BKRW-12.64%
6.53 BKRW+11.61%
5.85 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Binex Co Stock analysis

What does Binex Co do? Binex Co Ltd generates revenue through the manufacturing and sale of pharmaceutical products including digestive system agents, circulatory system agents, ulcer agents, antacids, anti-inflammatory agents, analgesics, gastrointestinal tract regulators, antispasmodics, antiemetic drugs, antihistamines, laxatives, antihypertensive and urinary agents, antibacterial and antibiotic agents, cough and cold remedies, anti-diabetic medicines, ophthalmic solutions, vitamins, nutrients, and various ointments and creams. The company also produces bio medicines and raw materials. Binex Co Ltd distributes its products domestically within Busan and to overseas markets, targeting healthcare providers, pharmacies, and hospitals that purchase pharmaceuticals for patient care and treatment. The firm's product portfolio covers a wide range of therapeutic areas, including gastrointestinal health, cardiovascular support, pain management, respiratory care, and chronic disease management. By offering both branded and generic pharmaceutical solutions, Binex Co Ltd serves diverse customer segments across the domestic and international pharmaceutical markets, leveraging its manufacturing capabilities to meet regional healthcare demands. Binex Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Binex Co stock

Current Liabilities of Binex Co is 4.39 B KRW in 2025.

Current Liabilities of Binex Co changed from 72.51 B KRW to 4.39 B KRW, representing a -93.94% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Binex Co since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Binex Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Binex Co

All Key Metrics — Binex Co